Sublocade treatment is a once-monthly, extended-release buprenorphine injection used for opioid use disorder. It delivers a steady medication level for 28–30 days to reduce cravings and withdrawal. At Road To Recovery’s Ontario clinics, patients can start quickly through a same‑day intake model and receive coordinated psychiatry referrals when needed.

By BRIAN TAYLOR · Last updated: April 22, 2026

Start Here: Quick Guide & Table of Contents

Sublocade is a monthly buprenorphine injection that stabilizes brain receptors to reduce opioid cravings and withdrawal for 28–30 days. This guide explains what Sublocade is, why it matters, how it works, when it’s used, best practices, tools, resources, and five must‑answer questions to help you decide your next step.

Use this section to get oriented, then jump to what you need:

• What Sublocade treatment is and how it differs from daily medications
• Why monthly injections improve adherence and stability over time
• How the process works at Road To Recovery (intake to maintenance)
• When Sublocade makes sense vs. Suboxone or methadone
• Best practices for a safer, smoother first year on treatment
• Tools and resources for ongoing recovery and mental health support
• Five common questions answered clearly in plain language

Overview

Sublocade treatment provides continuous buprenorphine for a full month through a small abdominal injection. Patients stabilized on daily buprenorphine for 7+ days can transition to monthly injections, often starting with two 300 mg doses, then 100 mg monthly. Clinics track progress with brief monthly visits and supportive care.

At Road To Recovery, we’ve built a same‑day intake pathway so new opioid use disorder patients meet a nurse and a physician on day one. Many who prefer fewer daily decisions benefit from once‑monthly care anchored by routine follow‑ups, urine toxicology monitoring, and coordinated mental health support when needed.

What Is Sublocade Treatment?

Sublocade is an FDA‑approved, extended‑release buprenorphine injection given monthly to treat opioid use disorder. It creates a stable medication level for 28–30 days, reducing cravings and withdrawal without the need for daily dosing. Patients typically qualify after stabilizing on daily buprenorphine for at least a week.

In practical terms, Sublocade replaces the daily routine of sublingual buprenorphine/naloxone with a monthly clinic visit. The medication forms a small depot under the skin and releases gradually. Many patients report fewer ups and downs between doses and more time to focus on therapy, work, and family responsibilities.

If you want a deeper dive into what to expect on injection day, see our step‑by‑step Sublocade injection treatment guide.

Why Sublocade Matters

Monthly buprenorphine can improve adherence, protect against missed doses, and support recovery stability. Fewer daily decisions reduce relapse risk triggers, while consistent receptor coverage limits withdrawal and cravings. For many, that translates into steadier work, family life, and mental health progress.

Recovery is rarely linear. Daily medications work well, but missed or delayed doses can create windows of vulnerability. Sublocade’s 28–30 days of steady exposure remove dozens of daily choice points each month. In our experience across Ontario communities, that consistency supports therapy engagement, sleep regularity, and return‑to‑work planning.

Because Road To Recovery also coordinates psychiatry referrals (local or virtual), we can align monthly injections with mental health care and counseling, which strengthens outcomes and reduces the friction of multiple appointments.

How Sublocade Works (Step by Step)

Sublocade works by forming a small depot under the skin that releases buprenorphine continuously for a month. Patients stabilize on daily buprenorphine for 7+ days, receive a 300 mg injection for the first two months in many cases, then continue 100 mg monthly with check‑ins, monitoring, and supportive counseling.

1. Stabilize on daily buprenorphine: Most patients use sublingual buprenorphine/naloxone for at least 7 days, reaching a stable daily dose.
2. Eligibility assessment: A clinician confirms medical history, medications, and goals, then reviews safety, side effects, and consent.
3. Injection visit: A small subcutaneous shot in the abdominal area; the visit typically takes 15–30 minutes including observation.
4. Initial dosing plan: Many start with 300 mg monthly for two months, then move to 100 mg monthly; some continue 300 mg if clinically indicated.
5. Monthly follow‑ups: Brief check‑ins, recovery coaching, and urine toxicology support accountability and safety.
6. Long‑term maintenance: Steady‑state is often achieved after several doses (commonly 4–6 months), at which point many patients feel consistently stable.

For a broader perspective on why medication‑assisted treatment (MAT) improves health and function, explore our MAT benefits overview.

Where Sublocade Fits Among OAT Options

Sublocade is one option within Opioid Agonist Therapy (OAT), alongside daily sublingual buprenorphine/naloxone and methadone. It’s ideal when monthly dosing, discreet care, and reduced day‑to‑day decision fatigue are priorities. Daily options may suit those who prefer frequent dose adjustments or structured pharmacy contact.

Each path has trade‑offs. Some patients want structure (e.g., daily pharmacy contact early on). Others need flexibility and privacy that monthly injections provide. Road To Recovery offers all three under one network, so your plan can evolve as your life changes—without switching providers.

Feature	Sublocade (Monthly)	Suboxone (Daily)	Methadone (Daily)
Dosing frequency	Every 28–30 days	Once or twice daily	Once daily
Clinic/pharmacy time	1 brief visit/month	Pharmacy visits; some take‑homes	Pharmacy visits; gradual take‑homes
Decision points	Very few	Daily	Daily
Adjustability	Monthly	High (daily)	High (daily)
Who may prefer	Those wanting privacy, consistency	Those wanting flexible self‑titration	Those who respond best to full agonists

Want a head‑to‑head on daily options? Read our balanced comparison, Suboxone vs. methadone, then discuss where Sublocade might fit in your longer‑term plan.

Best Practices for Starting and Staying on Sublocade

The best start includes clear goals, at least 7 days of stable daily buprenorphine, and a plan for the first 3–6 injections. Pair monthly shots with counseling, sleep routines, and relapse‑prevention strategies. Carry naloxone, schedule check‑ins, and add psychiatry support if mood, trauma, or anxiety are barriers.

• Clarify goals early: Identify top 3 outcomes (e.g., “no morning withdrawal,” “return to work by 90 days,” “repair family trust”).
• Stabilize before switching: Most patients do well moving to injections after at least 7 days on sublingual buprenorphine.
• Expect an adjustment period: It often takes 2–3 injections to find your rhythm; many reach steady‑state by 4–6 months.
• Anchor routines: Sleep and meals at consistent times reduce vulnerability windows; aim for regular bed and wake times.
• Pair with counseling: Monthly medication supports—but does not replace—therapy, peer support, or skills coaching.
• Safety first: Keep naloxone accessible and teach loved ones how to use it; avoid mixing with sedatives unless prescribed.
• Use your team: We coordinate psychiatry referrals (local or virtual) when mood, PTSD, or psychosis symptoms complicate recovery.

For long‑term perspective on buprenorphine outcomes, see our evidence roundup in the buprenorphine effectiveness guide.

Tools & Resources for Patients and Families

Reliable recovery tools include a structured intake pathway, monthly follow‑ups, family education, and mental health referrals. Road To Recovery provides same‑day OAT intake, judgment‑free care, and access to counseling and psychiatry coordination, so medical and psychological needs are addressed together.

• Same‑day intake: New OUD patients meet a nurse and physician the day they start, reducing delays and uncertainty.
• Secure online intake portal: Begin the process from home to save time and lower stress on day one.
• Judgment‑free clinic culture: Confidential care that welcomes family involvement with your consent.
• Mental health & psychiatry support: We coordinate local or virtual referrals to align care plans.
• Education library: Explore paths in our recovery options primer and OAT explainer.

Considering a switch to monthly injections? Talk with our team about your goals and routines. A 15–30 minute monthly visit can replace dozens of daily decisions and keep you centered on recovery work that matters most.

Case Studies & Real‑World Examples

Monthly injections help reduce decision fatigue, keep schedules predictable, and support therapy engagement. In our clinics, patients who struggled with daily dosing often report steadier sleep by month two and fewer craving spikes after 3–4 injections, creating space for work, family, and counseling.

• Patient A: A young parent juggling shift work missed several daily doses each month. After two 300 mg injections, they reported fewer morning symptoms and successfully aligned therapy sessions to the week after each shot.
• Patient B: Returning to school made daily pharmacy visits tough. Monthly injections reduced time away from classes, and by month four, they described energy and focus levels as “steady” across exam weeks.
• Patient C: With co‑occurring anxiety, daily dosing amplified worry. Transitioning to Sublocade cut daily choice points, and with psychiatry support, panic symptoms eased within the first semester back at work.

These scenarios are composites that reflect frequent patterns we see across Ontario. Your plan will be tailored, and you can move between OAT options as your needs change—without restarting care elsewhere.

5 Common Questions Answered Clearly

The five most common Sublocade questions cover eligibility, what injection day feels like, side effects, how it compares with Suboxone and methadone, and how to handle missed appointments. Here are concise answers to help you decide whether monthly treatment fits your life.

1) Who qualifies for Sublocade treatment?

Adults with opioid use disorder who stabilize on daily buprenorphine for at least 7 days may be eligible. Your clinician reviews medical history, medications, pregnancy status, and goals. If you’re a fit, the first 1–2 injections often use 300 mg before moving to 100 mg monthly.

2) What should I expect on injection day?

Plan 15–30 minutes. After a brief check‑in, your clinician delivers a small subcutaneous injection in the abdominal area. Mild soreness at the site is common for 1–3 days. You can usually return to regular activities the same day unless your care team advises otherwise.

3) What are the most common side effects?

Typical effects include injection‑site discomfort, constipation, headache, or nausea. Many are mild and settle within days. Call your clinic if symptoms feel severe or persist. Avoid alcohol and non‑prescribed sedatives. Keep naloxone handy and teach loved ones how to use it.

4) How does Sublocade compare with Suboxone or methadone?

Sublocade trades daily decisions for a monthly routine and consistent receptor coverage. Suboxone offers high day‑to‑day adjustability. Methadone can be ideal for people who respond better to a full agonist. Your history, preferences, and stability goals drive the choice—and you can switch later.

5) What happens if I miss my monthly injection?

Call the clinic as soon as possible. There’s usually a grace window to reschedule before cravings or withdrawal return. If more time passes, your team may use a brief bridge with daily buprenorphine and then resume Sublocade. Communication keeps you safe and comfortable.

Local considerations for your area

• Plan visits around local rush periods and weather; winter storms can affect clinic timing in Ontario communities, so book earlier in the day.
• During holidays, schedule the next injection 3–7 days in advance to avoid gaps while clinics adjust hours.
• If work or school shifts rotate, request a standing appointment (same week each month) to align with your local routine.

Frequently Asked Questions

These concise answers address practical issues patients raise most: switching safely, driving after injections, take‑home concerns, and how Sublocade supports people trying to stop alcohol or other substances during recovery.

Conclusion & Next Steps

Sublocade treatment offers month‑long stability that reduces cravings, withdrawal, and daily decision fatigue. It pairs best with counseling, safety planning, and predictable routines. If you value privacy and consistency, a 15–30 minute monthly visit can anchor your recovery without daily dosing.

Key takeaways

• Sublocade is a monthly buprenorphine injection that provides 28–30 days of coverage.
• Many start with two 300 mg doses, then continue at 100 mg monthly.
• Monthly routines reduce decision fatigue and support therapy engagement.
• You can move between OAT options (Sublocade, Suboxone, methadone) as life changes.
• Road To Recovery offers same‑day intake and psychiatry coordination across Ontario.

Action steps

• Skim the Sublocade injection guide for injection‑day details.
• Review our OAT explainer to see how options compare over time.
• Bookmark the MAT benefits overview and share it with a supporter.
• When you’re ready, map a switch timeline with your care team and set a standing monthly visit.

Ready to explore whether monthly injections fit your life? Our judgment‑free team can help you plan a safe, comfortable transition and build a recovery routine that lasts.

Related Reading from Road To Recovery

Dig deeper into OAT choices, long‑term buprenorphine data, and practical recovery planning. These articles expand on day‑one expectations, daily vs. monthly trade‑offs, and how to align medication with therapy and life goals for durable progress.

If you’re comparing daily and monthly paths, our Suboxone vs. methadone comparison clarifies differences in structure, side effects, and lifestyle fit. For a big‑picture plan, pair that with Opioid Use Disorder Recovery Options and our buprenorphine effectiveness guide.